Cisatracurium Omega Multi-Dose recall in Canada: potential for medication error
In plain language
This recall involves Cisatracurium Omega Multi-Dose (Cisatracurium Besylate Injection) sold in Canada. It's being recalled because a temporary change in the vial's metal seal colour could lead to medication errors. Healthcare professionals should be aware of this change to prevent confusion with other injectable products.
What to do
- Healthcare professionals should note the temporary change in the ferrule (metal seal) colour from teal to red.
- Confirm proper product selection to avoid confusion with other injectable products.
- Be aware of the potential for errors from inadvertent selection and administration of neuromuscular blocking agents.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Cisatracurium Omega Multi-Dose Cisatracurium, 20 mg/10 mL (2 mg/mL); 10mL vial
Model: DIN 02408813
Why this matters
Potential for medication error
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: DIN 02408813
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Potential for medication error
What should consumers do?
Healthcare professionals should note the temporary change in the ferrule (metal seal) colour from teal to red. Confirm proper product selection to avoid confusion with other injectable products. Be aware of the potential for errors from inadvertent selection and administration of neuromuscular blocking agents.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Potential for medication error
When was this product recalled?
This product was recalled on May 25, 2020.
Is the Cisatracurium Omega Multi-Dose brand affected by this recall?
Yes, Cisatracurium Omega Multi-Dose products are affected by this recall. This recall involves Cisatracurium Omega Multi-Dose (Cisatracurium Besylate Injection) sold in Canada. It's being recalled because a temporary change in the vial's metal seal colour could lead to medication errors. Healthcare professionals should be aware of this change to prevent confusion with other injectable products.